Results 171 to 180 of about 22,288 (223)
Real-World Outcomes of Aflibercept 2 mg Using a Treat-and-Extend Protocol for Neovascular Age-Related Macular Degeneration: A 24-Month Retrospective Study in a Chinese Population. [PDF]
Drug Des Devel TherQi Y, Cheng A, Xu J, Zhang C, Li S.
europepmc +1 more source
Safety and Efficacy of cceAAV-aflibercept-Fc-YTE (F-CRG-B191): A Gene Therapy for Neovascular Age-Related Macular Degeneration. [PDF]
Invest Ophthalmol Vis SciShi J +7 more
europepmc +1 more source
Exudative non-neovascular age-related macular degeneration
Graefe's Archive for Clinical and Experimental Ophthalmology, 2020 To describe the clinical and multimodal imaging (MMI) features of age-related macular degeneration (AMD) eyes presenting with intraretinal exudation and no evidence of neovascularization or structural alterations of native retinal vessels.This was a retrospective review of the MMI and electronic health records for 3 consecutive patients presenting with
Tommaso Bacci +3 more
openaire +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Neovascular Age-Related Macular Degeneration
Ophthalmologica, 2012<i>Purpose:</i> Neovascular age-related macular degeneration (AMD) is a leading cause of blindness, with an increasing incidence as the elderly population expands. Large, multi-center, randomized, clinical trials have been conducted exploring the safety and efficacy of anti-VEGF treatments. This paper aims to discuss the safety and efficacy
VERITTI, Daniele +2 more
openaire +3 more sources
Neovascular Age-Related Macular Degeneration
2015Age-related macular degeneration (AMD) is the leading cause of severe vision loss in individuals over the age of 50 years. Choroidal neovascularization (CNV) is the hallmark of 'wet' or 'exudative' AMD, and is responsible for approximately 90% of cases of severe vision loss due to AMD. Vascular endothelial growth factor (VEGF) is a key component in the
Jack, Shao +2 more
openaire +3 more sources
Macular translocation for neovascular age-related macular degeneration
Cochrane Database of Systematic Reviews, 2008Macular translocation has been proposed by vitreoretinal surgeons to displace the neuroretinal tissue onto healthy retinal pigment epithelium and choroid when the macula has been invaded by subretinal neovascularisation.This review aims at assessing the effectiveness of macular translocation for preserving or improving vision in patients with ...
Eandi CM +2 more
openaire +3 more sources
Imaging in Neovascular Age-Related Macular Degeneration
Seminars in Ophthalmology, 2011Imaging plays an essential role in the diagnosis and treatment of age-related macular degeneration (AMD). This review describes the imaging modalities most commonly employed by ophthalmologists caring for patients with neovascular AMD. Imaging modalities discussed include fluorescein angiography, optical coherence tomography, indocyanine green ...
Adam J, Gess +2 more
openaire +2 more sources
Age-related Macular Degeneration and Choroidal Neovascularization
American Journal of Ophthalmology, 1993The neovascular variant of age-related macular degeneration is amenable to laser photocoagulation treatment within well-defined guidelines established by clinical trials. However, only a limited number of patients meet eligibility criteria for this form of treatment, principally because of the ill-defined, or occult nature, of the choroidal ...
K B, Freund +2 more
openaire +2 more sources
Hyperopia and Neovascularization in Age-related Macular Degeneration
Ophthalmology, 1993Refractive errors for phakic eyes of patients referred with age-related macular degeneration were reviewed to determine whether some range of refractive error might be a risk factor for the neovascular form.The authors compared refractive errors of 198 patients with unilateral neovascular disease with refractive errors of 129 patients with bilateral ...
M A, Sandberg +4 more
openaire +2 more sources